Tumor-targeting intravenous lipid emulsion of paclitaxel: Characteristics, stability, toxicity, and toxicokinetics

Journal of Pharmaceutical Analysis - Tập 12 - Trang 901-912 - 2022
Jun Ye1,2, Lin Li1,2, Jiye Yin3, Hongliang Wang1,2, Renjie Li1,2, Yanfang Yang1,2, Yongbiao Guan3, Xuejun Xia2, Yuling Liu1
1State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China
2Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China
3National Beijing Center for Drug Safety Evaluation and Research, Beijing Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, 100850, China

Tài liệu tham khảo

Spencer, 1994, Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer, Drugs, 48, 794, 10.2165/00003495-199448050-00009 Panchagnula, 1998, Pharmaceutical aspects of paclitaxel, Int. J. Pharm., 172, 1, 10.1016/S0378-5173(98)00188-4 Rowinsky, 1995, Paclitaxel (taxol), N. Engl. J. Med., 332, 1004, 10.1056/NEJM199504133321507 Xiang, 2021, Nanomedicine from amphiphilizedprodrugs: Concept and clinical translation, Adv. Drug Deliv. Rev., 179, 10.1016/j.addr.2021.114027 Gonzalez-Valdivieso, 2021, Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation, Int. J. Pharm., 599, 10.1016/j.ijpharm.2021.120438 Chen, 2022, Emerging nanomedicines of paclitaxel for cancer treatment, J. Control. Release, 342, 280, 10.1016/j.jconrel.2022.01.010 Li, 2022, Drug discovery is an eternal challenge for the biomedical sciences, Acta Mater. Med., 1, 1 Zheng, 2021, An overview of polymeric nanomicelles in clinical trials and on the market, Chin. Chem. Lett., 32, 243, 10.1016/j.cclet.2020.11.029 Sofias, 2017, The battle of “nano” paclitaxel, Adv. Drug Deliv. Rev., 122, 20, 10.1016/j.addr.2017.02.003 Gupta, 2016, Nanoemulsions: Formation, properties and applications, Soft Matter, 12, 2826, 10.1039/C5SM02958A Singh, 2017, Nanoemulsion: Concepts, development and applications in drug delivery, J. Control. Release, 252, 28, 10.1016/j.jconrel.2017.03.008 Hörmann, 2016, Drug delivery and drug targeting with parenteral lipid nanoemulsions - A review, J. Control. Release, 223, 85, 10.1016/j.jconrel.2015.12.016 Machado, 2022, Complex nanoemulsion for vitamin delivery: Droplet organization and interaction with skin membranes, Nanoscale, 14, 506, 10.1039/D1NR04610A Rai, 2018, Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: Formulation development, stability issues, basic considerations and applications, J. Control. Release, 270, 203, 10.1016/j.jconrel.2017.11.049 Gao, 2021, The length of disulfide bond-containing linkages impacts the oral absorption and antitumor activity of paclitaxel prodrug-loaded nanoemulsions, Nanoscale, 13, 10536, 10.1039/D1NR01359A Abu-Fayyad, 2018, Development and in-vitro characterization of nanoemulsions loaded with paclitaxel/γ-tocotrienol lipid conjugates, Int. J. Pharm., 536, 146, 10.1016/j.ijpharm.2017.11.062 Jing, 2014, A novel polyethylene glycol mediated lipid nanoemulsion as drug delivery carrier for paclitaxel, Nanomedicine, 10, 371, 10.1016/j.nano.2013.07.018 Bu, 2014, A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer, Int. J. Pharm., 471, 206, 10.1016/j.ijpharm.2014.05.039 Pires, 2009, Use of cholesterol-rich nanoparticles that bind to lipoprotein receptors as a vehicle to paclitaxel in the treatment of breast cancer: Pharmacokinetics, tumor uptake and a pilot clinical study, Cancer Chemother. Pharmacol., 63, 281, 10.1007/s00280-008-0738-2 Xia, 2011, Formulation, characterization and hypersensitivity evaluation of an intravenous emulsion loaded with a paclitaxel-cholesterol complex, Chem. Pharm. Bull. (Tokyo), 59, 321, 10.1248/cpb.59.321 Ye, 2016, Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors, Oncol. Rep., 36, 399, 10.3892/or.2016.4787 Ye, 2016, Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel-cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines, Int. J. Nanomedicine, 11, 4125, 10.2147/IJN.S113638 Ye, 2017, Vitamin E-rich nanoemulsion enhances the antitumor efficacy of low-dose paclitaxel by driving Th1 immune response, Pharm. Res., 34, 1244, 10.1007/s11095-017-2141-3 Ye, 2021, Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations, J. Nanobiotechnology, 19 1996 Dong, 2020, Self-assembled lecithin/chitosan nanoparticles based on phospholipid complex: A feasible strategy to improve entrapment efficiency and transdermal delivery of poorly lipophilic drug, Int. J. Nanomedicine, 15, 5629, 10.2147/IJN.S261162 Ye, 2020, Targeted delivery of chlorogenic acid by mannosylated liposomes to effectively promote the polarization of TAMs for the treatment of glioblastoma, Bioact. Mater., 5, 694, 10.1016/j.bioactmat.2020.05.001 Lu, 2017, Study on the stabilization mechanism of crude oil emulsion with an amphiphilic polymer using the β-cyclodextrin inclusion method, RSC Adv., 7, 8156, 10.1039/C6RA28528G Ma, 2013, Comparative study on pharmacokinetics and tissue distribution of a novel microemulsion based on the paclitaxel/L-OH lipid complex and paclitaxel injection in cremophor, Acta Pharm. Sin., 48, 1698 Ruttala, 2017, Layer-by-layer assembly of hierarchical nanoarchitectures to enhance the systemic performance of nanoparticle albumin-bound paclitaxel, Int. J. Pharm., 519, 11, 10.1016/j.ijpharm.2017.01.011 Ruttala, 2015, Liposome encapsulated albumin-paclitaxel nanoparticle for enhanced antitumor efficacy, Pharm. Res., 32, 1002, 10.1007/s11095-014-1512-2 Ghavidel, 2020, Pickering/non-Pickering emulsions of nanostructured sulfonated lignin derivatives, ChemSusChem, 13, 4567, 10.1002/cssc.202000965 Desai, 2019, Enhanced oral bioavailability and brain uptake of Darunavir using lipid nanoemulsion formulation, Colloids Surf. B Biointerfaces, 175, 143, 10.1016/j.colsurfb.2018.11.057 Song, 2020, Ultrasound-assisted preparation of exopolysaccharide/nystatin nanoemulsion for treatment of vulvovaginal candidiasis, Int. J. Nanomedicine, 15, 2027, 10.2147/IJN.S241134 Manca, 2016, Combination of argan oil and phospholipids for the development of an effective liposome-like formulation able to improve skin hydration and allantoin dermal delivery, Int. J. Pharm., 505, 204, 10.1016/j.ijpharm.2016.04.008 Sentis, 2020, Simultaneous screening of the stability and dosimetry of nanoparticles dispersions for in vitro toxicological studies with static multiple light scattering technique, Toxicol. Vitro, 69, 10.1016/j.tiv.2020.104972 Hong, 2017, Influence of lysolecithin and Tween 80 on the colloidal stability of branched chain amino acids in a nanosuspension system, Food Chem., 221, 606, 10.1016/j.foodchem.2016.11.131 Jain, 2019, In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug delivery, Artif. Cells Nanomed, Biotechnol., 47, 524 Liu, 2018, Use of cilomilast-loaded phosphatiosomes to suppress neutrophilic inflammation for attenuating acute lung injury: The effect of nanovesicular surface charge, J. Nanobiotechnology, 16 Bhattacharjee, 2016, DLS and zeta potential - What they are and what they are not?, J. Control. Release, 235, 337, 10.1016/j.jconrel.2016.06.017 Rowinsky, 1993, Clinical toxicities encountered with paclitaxel (taxol), Semin. Oncol., 20, 1 Vishnu, 2011, Safety and efficacy of nab-paclitaxel in thetreatment of patients with breast cancer, Breast Cancer (Auckl), 5, 53 Desai, 2006, Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel, Clin. Cancer Res., 12, 1317, 10.1158/1078-0432.CCR-05-1634